Universal Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $2.8B-3.8% YoYTTM through 30 Jun 2026
Net Income $19.1M-79.9% YoYTTM through 30 Jun 2026
Free Cash Flow $164.4MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 17.5% |
| EBITDA Margin | 6.7% |
| Operating Margin | 5.8% |
| Net Margin | 0.7% |
Returns
2.3%ROE
1.2%ROA
1.0%ROIC
Balance Sheet Health
Debt / Equity0.64x
Current Ratio2.57x
Net Debt$842.1M
Cash & Equivalents$173.6M
Quality Metrics
Altman Z-Score2.53
Piotroski F-Score5 / 9
FCF Margin5.8%
Earnings-Beat Rate33.3%
Multi-Year Trend
RevenueFY2026: $2.9B
Diluted EPS$0.76TTMFY2026: $1.30
Dividend
$2.47Per share, FY20265.68%Yield-4.4%5-yr growth
Capital Allocation
Capex Intensity1.9%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Tobacco Operations | $2.6B | -1.2% | View detailsUncommitted tobacco inventory levels are expected to return to the target range during fiscal year 2027. |
| Ingredients Operations | $348.1M | +2.8% | View detailsUniversal has initiated enhancements at its Shank's operation to drive efficiency and financial performance. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.